Location History:
- Rancho Cucamonga, CA (US) (2002)
- Riverside, CA (US) (2015 - 2022)
Company Filing History:
Years Active: 2002-2022
Title: Jie Fei Ding: Innovator in Pharmaceutical Advancements
Introduction
Jie Fei Ding is a notable inventor based in Riverside, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of highly purified recombinant human insulin and long-term sustained release pharmaceutical compositions.
Latest Patents
Ding holds 3 patents that showcase his innovative work. His latest patents include methods for producing highly purified recombinant human insulin (RHI) with a purity of 99.0% (w/w) or greater. These methods ensure a Total Impurity of 0.8% (w/w) or less, and an impurity C of 0.1% (w/w) or less. Additionally, he has developed pharmaceutical compositions for long-term sustained release of bisphosphonate drugs, which can be used to treat various bone diseases, including osteoporosis.
Career Highlights
Ding is currently employed at Amphastar Pharmaceuticals, Inc., where he continues to push the boundaries of pharmaceutical innovation. His work has been instrumental in enhancing the quality and efficacy of medications available to patients.
Collaborations
Ding collaborates with esteemed colleagues such as Jack Yongfeng Zhang and Mary Zi-Ping Luo, contributing to a dynamic and innovative work environment.
Conclusion
Jie Fei Ding's contributions to pharmaceutical science exemplify the impact of innovation in healthcare. His patents and ongoing work at Amphastar Pharmaceuticals, Inc. highlight his commitment to improving patient outcomes through advanced drug formulations.